The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and genomic landscape of EGFR-mutant lung cancers (LCs) with squamous and adenosquamous differentiation.
 
Arielle Elkrief
Other Relationship - Canadian Institutes of Health Research (CIHR); Cedars Cancer Center; Royal College of Surgeons and Physicians of Canada
 
Christina J. Falcon
No Relationships to Disclose
 
Allison L. Richards
No Relationships to Disclose
 
Alexandria Dymun
No Relationships to Disclose
 
Paul K. Paik
Honoraria - Bicara Therapeutics; Crown Bioscience; EMD Serono; Janssen Oncology; Mirati Therapeutics; Takeda
Consulting or Advisory Role - Bicara Therapeutics; Crown Bioscience; EMD Serono; Janssen Oncology; Mirati Therapeutics; Takeda
Research Funding - Bicara Therapeutics; Boehringer Ingelheim; EMD Serono
 
Rania G. Aly
No Relationships to Disclose
 
Natasha Rekhtman
Honoraria - Physicans' Education Resource
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bridge Medicines; Daiichi Sankyo/UCB Japan; Earli; Epizyme; Genentech/Roche; Harpoon Therapeutics; Ipsen; Jazz Pharmaceuticals; Kowa; Merck; Syros Pharmaceuticals; Syros Pharmaceuticals
Research Funding - Merck (Inst); Roche/Genentech (Inst)
 
Alvaro Quintanal-Villalonga
No Relationships to Disclose
 
Helena Alexandra Yu
Consulting or Advisory Role - AstraZeneca; Black Diamond Therapeutics; Blueprint Medicines; C4 Therapeutics; Cullinan Oncology; Daiichi Sankyo; Janssen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Blueprint Medicines; Cullinan Oncology (Inst); Daiichi Sankyo (Inst); Erasca, Inc (Inst); Janssen Oncology (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Lilly
Other Relationship - Astellas Pharma